SCHEMBL5726691

SCHEMBL5726691

Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(Cl)cccc1Cl

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 10/20 0.78
▸ CCNB2 O95067 9/20 0.78
▸ CCNB1 P14635 9/20 0.78
▸ CCNB3 Q8WWL7 9/20 0.78
▸ JAK2 O60674 9/20 0.78
▸ CDK2 P24941 4/20 0.78
▸ JAK1 P23458 4/20 0.78
▸ TYK2 P29597 4/20 0.78
▸ JAK3 P52333 4/20 0.78
▸ EIF2AK2 P19525 3/20 0.78
▸ CDK4 P11802 3/20 0.78
▸ CCNA2 P20248 3/20 0.78
▸ CCND1 P24385 3/20 0.78
▸ MAPK3 P27361 3/20 0.78
▸ MAPK1 P28482 3/20 0.78
▸ KDR P35968 3/20 0.78
▸ CSNK1A1 P48729 3/20 0.78
▸ CSNK1D P48730 3/20 0.78
▸ CSNK1E P49674 3/20 0.78
▸ GSK3A P49840 3/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5726847 0.94 CDK1 (0.86) CDK1CCNB2CCNB1CCNB3JAK2
SCHEMBL5727180 0.90 CCNB2 (0.70) CDK1CCNB2CCNB1CCNB3JAK2
SCHEMBL6100975 0.88 CCNB2 (0.72) CDK1CCNB2CCNB1CCNB3JAK2
Jnj-7706621 SCHEMBL1060773 0.88 CDK1 (1.00) CDK1CCNB2CCNB1CCNB3JAK2
SCHEMBL5727313 0.88 CDK1 (0.80) CDK1CCNB2CCNB1CCNB3JAK2
SCHEMBL5727275 0.85 CDK1 (0.79) CDK1CCNB2CCNB1CCNB3JAK2
SCHEMBL5726198 0.84 CDK1 (0.74) CDK1CCNB2CCNB1CCNB3JAK2
SCHEMBL5986060 0.83 CCNB2 (0.79) CDK1CCNB2CCNB1CCNB3JAK2
SCHEMBL5726202 0.83 CCNB2 (1.00) CDK1CCNB2CCNB1CCNB3JAK2
SCHEMBL5964778 0.82 CCNB2 (0.71) CDK1CCNB2CCNB1CCNB3JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1712550-A2 Substituted triazole diamine derivatives as kinase inhibitors Ortho-McNeil Pharmaceutical, Inc. (US) 2006-10-18 — — EP disclosed
EP-1355889-B1 SUBSTITUTED TRIAZOLE DIAMINE DERIVATIVES AS KINASE INHIBITORS ORTHO MCNEIL PHARM INC (US) 2006-06-07 — — EP disclosed
Send feedback